Alessandro Bonifazi
@AleBonifazi
Followers
105
Following
98
Statuses
44
Medicinal chemist interested in structure-based drug design and GPCRs signaling. Opinions are my own.
Joined May 2011
RT @JGarciaNafria: Delighted to get this out!we describe bitopic binding mode to the dopamine 3 receptor, including a reorganization of TM1…
0
19
0
RT @anewman2014: Check out these beautiful new bivalents led by @AleBonifazi Pharmacological and Physicochemical Properties Optimization f…
0
7
0
Our latest review studying the new targets of interest for our upcoming drug discovery projects:
0
0
4
RT @SleepResearch_: Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment o…
0
2
0
RT @Emma_Gogarnoiu: I'm proud to share the work from my time as an NIH/NIDA postbac in @anewman2014's lab. We developed dopamine D3R/D2R li…
0
4
0
RT @anewman2014: Illuminating the monoamine transporters: Fluorescently labelled ligands to study dopamine, serotonin and norepineph… https…
0
15
0
RT @XOanAxon: Well I guess our paper has spread faster than I expected for a Sunday! Here is a short tweetorial for our recent @KhaliqLab s…
0
30
0
RT @sevakat1: Fitting molecular puzzle piece by piece by V-SYNTHES. Our new fast Giga-scale virtual screening is out in Nature. Kudos to V-…
0
31
0
New tools for structural biology and molecular pharmacology @ACSBioMed - Achieving receptor subtype selectivity modulating linkers' chirality and ligands' poses. Thanks to @FBattiti, @saheemazaidi, @sevakat1 and @anewman2014 for believing in this project.
4
4
18
RT @anewman2014: Shout out to @GiselaACamacho and @AndreaCasiragh9 for our latest contribution to #FluorescentFriday: Illuminating the nore…
0
4
0
RT @anewman2014: Super excited to introduce our newest foray into bivalent ligands with a promising future. Novel Dual-Target μ-Opioid Re…
0
19
0
3
5
23
RT @anewman2014: Check out our latest review highlighting work from @tkyaya, @chloejordanphd, @AleBonifazi and twitterless Dr. Xi! New Dru…
0
10
0
RT @NIDAnews: NEWS: NIDA is pleased to announce the appointment of a new Scientific Director, Dr. Amy Hauck Newman. Dr. Newman has served a…
0
28
0
RT @ACSBioMed: "Medicinal Chemistry: From Targets to Therapies” – Celebrating 10 years of ACS Medicinal Chemistry Letters hitting the bull’…
0
8
0